An Interview With Christine Clemson, PhD, of Entrada Therapeutics
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Christine Clemson, PhD, senior vice-president and global head of medical affairs at Entrada Therapeutics, about exon skipping therapies in Duchenne.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
More from Rare Care Podcast
An Interview With Rich Savino, Grandfather of a Boy With Duchenne
An Interview With Oncologist and Podcaster Kimberly Ku, MD, on 'Empathetic Communications'
An Interview With Avril Daly, President of Eurordis-Rare Diseases Europe
An Interview With Jim Palma, CEO of TargetCancer
Get summaries like this every morning.
Free AI-powered recaps of Rare Care Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.